Onconetix Sets 1-for-10 Reverse Split Effective November 6
ONCO is trading near its 52-week low of $0.38 (7.9% below the low) on light trading volume (0.2× avg).
Summary
Onconetix's board approved a 1-for-10 reverse split effective 12:01 a.m. ET on November 6, 2026, cutting outstanding shares from about 5,886,774 to roughly 588,677. The stock keeps the ONCO symbol and gets a new CUSIP, 68237Q500; authorized shares stay at 250,000,000 and fractional holders get cash. This is the second reverse split this year after the 1-for-10 executed May 21, and it comes with the shares at $0.35, below the 52-week low of $0.3801 and far under the $200 high. The split itself changes nothing about value, but it is a compliance move to hold the Nasdaq listing while the company carries a going concern warning and heavy dilution from the Seven Knots resale shares and the pending Series F conversion vote on November 10. Watch whether the post-split price holds above $1 and how the November 10 shareholder vote on issuing up to 154.9 million shares resolves.
Updates
· SEC 8-K — Onconetix's second 1-for-10 reverse split, effective 12:01 a.m. ET November 6, 2026, cuts outstanding shares from about 5,886,774 to roughly 588,677, with a new CUSIP 68237Q500.
At the time of this announcement, ONCO was trading at $0.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $0.38 to $200.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.